Disclosure 0001193125-26-363737-2

SEC FORM 4

$21,747.50

TREACE MEDICAL CONCEPTS, INC. (TMCI)

Purchase of 5,000 shares at $4.3495 per share.

Reporting Person Treace John T. · Officer Title Chief Executive Officer · Transaction Code P

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001193125-26-363737 · filed 2026-08-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TREACE MEDICAL CONCEPTS, INC. (TMCI)." Disclosed 2026-08-24. https://desqlong.com/cards/0001193125-26-363737-2 (retrieved 2026-09-26).